Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core set

Multiple Sclerosis Journal

Volumn 18, Issue 3, 2012, Pages 364-371

  Gijbels, Domien ^a   Dalgas, Ulrik ^b   Romberg, Anders ^c   De Groot, Vincent ^d   Bethoux, Francois ^e   Vaney, Claude ^f   Gebara, Benoit ^g   Medina, Carme Santoyo ^h   Maamâgi, Heigo ⁱ   Rasova, Kamila ^j   De Noordhout, Benoit Maertens ^k   Knuts, Kathy ^l   Feys, Peter ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b AARHUS UNIVERSITY   (Denmark)

^c Maskun Neurologinen Kuntoutuskeskus   (Finland)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e LERNER RESEARCH INSTITUTE   (United States)

^f Berner Klinik   (Switzerland)

^g National MS Center   (Belgium)

^h Hospital de Dia de Barcelona   (Spain)

ⁱ WEST TALLINN CENTRAL HOSPITAL   (Estonia)

^j CHARLES UNIVERSITY   (Czech Republic)

^k Centre Neurologique et de Réadaptation Fonctionelle Fraiture en Condroz   (Belgium)

^l Rehabilitation and MS Center   (Belgium)

more..

Author keywords

2 Minute Walk Test; 6 Minute Walk Test; multiple sclerosis; recommendations; Timed 25 Foot Walk; walking distance; walking speed

Indexed keywords

ADULT; AGED; ARTICLE; DISABILITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; GAIT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); MULTIPLE SCLEROSIS; VELOCITY; WALKING;

EID: 84857866698     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511420598     Document Type: Article

References (40)

1. Pearson OR, Busse ME, van Deursen RW, Wiles CM. Quantification of walking mobility in neurological disorders. QJM. 2004 ; 97: 463-475 (Pubitemid 39144594)
2. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain. 2001 ; 124: 962-973 (Pubitemid 32458508)
3. Heesen C, Bohm J, Reich C, Kasper J, Goebel M, Gold SM. Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable. Mult Scler. 2008 ; 14: 988-991
4. Goodman AD, Brown TR, Krupp LB, et al. Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet. 2009 ; 373: 732-738
5. Snook EM, Motl RW. Effect of exercise training on walking mobility in multiple sclerosis: a meta-analysis. Neurorehabil Neural Repair. 2009 ; 23: 108-116
6. Hutchinson B, Forwell SJ, Bennett S, Brown T, Karpatkin H, Miller D. Toward a consensus on rehabilitation outcomes in MS: gait and fatigue. Int J MS Care. 2009 ; 11: 67-78
7. Graham JE, Ostir GV, Fisher SR, Ottenbacher KJ. Assessing walking speed in clinical research: a systematic review. J Eval Clin Pract. 2008 ; 14: 552-562
8. Rasova K, Feys P, Henze T, et al. Emerging evidence-based physical rehabilitation for multiple sclerosis - towards an inventory of current content across Europe. Health Qual Life Outcomes. 2010 ; 8: 76
9. Fritz S, Lusardi M. White paper: "walking speed: the sixth vital sign". J Geriatr Phys Ther. 2009 ; 32: 2-5
10. Noonan V, Dean E. Submaximal exercise testing: clinical application and interpretation. Phys Ther. 2000 ; 80: 782-807 (Pubitemid 30620609)
11. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998 ; 158: 1384-1387
12. van Stel HF, Bogaard JM, Rijssenbeek-Nouwens LH, Colland VT. Multivariable assessment of the 6-min walking test in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001 ; 163: 1567-1571 (Pubitemid 32578757)
13. Pohl PS, Perera S, Duncan PW, Maletsky R, Whitman R, Studenski S. Gains in distance walking in a 3-month follow-up poststroke: what changes?. Neurorehabil Neural Repair. 2004 ; 18: 30-36 (Pubitemid 38252527)
14. Goldman MD, Marrie RA, Cohen JA. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler. 2008 ; 14: 383-390 (Pubitemid 351676433)
15. Gijbels D, Eijnde BO, Feys P. Comparison of the 2- and 6-Minute Walk Test in multiple sclerosis. Mult Scler. 2011 ;:
16. Eng JJ, Dawson AS, Chu KS. Submaximal exercise in persons with stroke: test-retest reliability and concurrent validity with maximal oxygen consumption. Arch Phys Med Rehabil. 2004 ; 85: 113-118 (Pubitemid 38049601)
17. Kelly JO, Kilbreath SL, Davis GM, Zeman B, Raymond J. Cardiorespiratory fitness and walking ability in subacute stroke patients. Arch Phys Med Rehabil. 2003 ; 84: 1780-1785 (Pubitemid 37509788)
18. Dobkin BH. Short-distance walking speed and timed walking distance: redundant measures for clinical trials?. Neurology. 2006 ; 66: 584-586 (Pubitemid 43739894)
19. Dean CM, Richards CL, Malouin F. Walking speed over 10 metres overestimates locomotor capacity after stroke. Clin Rehabil. 2001 ; 15: 415-421 (Pubitemid 32747098)
20. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001 ; 50: 121-127
21. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 ; 33: 1444-1452 (Pubitemid 14237132)
22. Dupont WD, Plummer WD. Power and sample size calculations for studies involving linear regression. Control Clin Trials. 1998 ; 19: 589-601 (Pubitemid 29057724)
23. Gijbels D, Alders G, Van HE, et al. Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures. Mult Scler. 2010 ; 16: 618-626
24. Fischer JS, Rudick RA, Cutter GR, Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler. 1999 ; 5: 244-250 (Pubitemid 29405620)
25. Moseley AM, Lanzarone S, Bosman JM, et al. Ecological validity of walking speed assessment after traumatic brain injury: a pilot study. J Head Trauma Rehabil. 2004 ; 19: 341-348 (Pubitemid 38938199)
26. Graham JE, Ostir GV, Kuo YF, Fisher SR, Ottenbacher KJ. Relationship between test methodology and mean velocity in timed walk tests: a review. Arch Phys Med Rehabil. 2008 ; 89: 865-872 (Pubitemid 351602242)
27. Eng JJ, Chu KS, Dawson AS, Kim CM, Hepburn KE. Functional walk tests in individuals with stroke: relation to perceived exertion and myocardial exertion. Stroke. 2002 ; 33: 756-761 (Pubitemid 34204003)
28. van Hedel HJ, Wirz M, Dietz V. Assessing walking ability in subjects with spinal cord injury: validity and reliability of 3 walking tests. Arch Phys Med Rehabil. 2005 ; 86: 190-196 (Pubitemid 40215278)
29. Paltamaa J, Sarasoja T, Leskinen E, Wikstrom J, Malkia E. Measuring deterioration in international classification of functioning domains of people with multiple sclerosis who are ambulatory. Phys Ther. 2008 ; 88: 176-190 (Pubitemid 351196711)
30. Bigland-Ritchie B, Cafarelli E, Vollestad NK. Fatigue of submaximal static contractions. Acta Physiol Scand Suppl. 1986 ; 556: 137-148 (Pubitemid 17227029)
31. Bethoux F, Bennett S. Evaluating walking in patients with multiple sclerosis: which assessment tools are useful in clinical practice?. Int J MS Care. 2011 ; 13: 4-14
32. Goldman MD, Motl RW, Rudick RA. Possible clinical outcome measures for clinical trials in patients with multiple sclerosis. Ther Adv Neurol Disord. 2010 ; 3: 229-239
33. Kaufman M, Moyer D, Norton J. The significant change for the Timed 25-foot Walk in the multiple sclerosis functional composite. Mult Scler. 2000 ; 6: 286-290
34. Rantanen T, Guralnik JM, Izmirlian G, et al. Association of muscle strength with maximum walking speed in disabled older women. Am J Phys Med Rehabil. 1998 ; 77: 299-305 (Pubitemid 28377945)
35. Dalgas U, Stenager E, Jakobsen J, et al. Resistance training improves muscle strength and functional capacity in multiple sclerosis. Neurology. 2009 ; 73: 1478-1484
36. Camarri B, Eastwood PR, Cecins NM, Thompson PJ, Jenkins S. Six minute walk distance in healthy subjects aged 55-75 years. Respir Med. 2006 ; 100: 658-665 (Pubitemid 43285753)
37. Barrett CL, Mann GE, Taylor PN, Strike P. A randomized trial to investigate the effects of functional electrical stimulation and therapeutic exercise on walking performance for people with multiple sclerosis. Mult Scler. 2009 ; 15: 493-504
38. Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM. Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed). 1982 ; 284: 1607-1608 (Pubitemid 12105148)
39. Leung AS, Chan KK, Sykes K, Chan KS. Reliability, validity, and responsiveness of a 2-min walk test to assess exercise capacity of COPD patients. Chest. 2006 ; 130: 119-125 (Pubitemid 44116849)
40. Barbeau H, Elashoff R, Deforge D, Ditunno J, Saulino M, Dobkin BH. Comparison of speeds used for the 15.2-meter and 6-minute walks over the year after an incomplete spinal cord injury: the SCILT Trial. Neurorehabil Neural Repair. 2007 ; 21: 302-306 (Pubitemid 46871861)